Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepa...
Leadership
Gerard J. Michel MBA, MS
CEO & Director
Martha S. Rook Ph.D.
Chief Operating Officer
Vojislav Vukovic M.D., M.Sc., Ph.D.
Chief Medical Officer
Sandra Pennell CPA
Chief Financial Officer
David Hoffman J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
Johnny John M.D.
Senior Vice President of Clinical Operations & Medical Affairs
